Ionizable phospholipids have been developed to enhance the delivery of mRNA and sgRNA for gene editing by selective organ targeting and endosomal membrane destabilization.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines
Journal of Nanobiotechnology Open Access 29 November 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Dowdy, S. F. Nat. Biotechnol. 35, 222–229 (2017).
Kulkarni, J. A. et al. Nucleic Acid Ther. 28, 146–157 (2018).
Jayaraman, M. et al. Agnew Chem. Int. Ed. 51, 8529–8533 (2012).
Gilleron, J. et al. Nat. Biotechnol. 31, 638–646 (2013).
Gustafson, H. H. et al. Nano Today. 10, 487–510 (2015).
Liu, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-020-00886-0 (2021).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
S.F.D. is a member of the scientific advisory board of Generation Bio, a gene therapy biotechnology company.
Rights and permissions
About this article
Cite this article
Jadhav, S.G., Dowdy, S.F. Overcoming delivery barriers with LNPs. Nat. Mater. 20, 575–577 (2021). https://doi.org/10.1038/s41563-021-00988-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-021-00988-3
This article is cited by
-
Advanced application of nanotechnology in active constituents of Traditional Chinese Medicines
Journal of Nanobiotechnology (2023)